The maximum dose is 75 mg within a 24-hour period. Like the anti-CGRP monoclonal antibodies, gepants were created to target migraine specifically. These medications have been shown to be effective ...

W hen it comes to treating a chronic condition like migraine, Western medicine is the new kid on the block, relatively speaking. After all, the vast majority of today’s pharmace ...

At AAN 2025, three posters presented the sustained long-term efficacy and real-world impact of Lundbeck’s Vyepti for migraine ...

Pfizer’s Vydura has become the first oral CGRP antagonist recommended for routine use by the NHS to prevent episodic migraine attacks, after being rejected earlier this year as an acute treatment.

SAN DIEGO -- Fremanezumab (Ajovy) cut monthly migraine days in children and adolescents with episodic migraine, according to the SPACE trial. The phase III study showed a reduction in monthly ...

Merck has announced that the antagonist of the calcitonin gene-related peptide (CGRP) receptor telcagepant has met the primary end points in two Phase III trials to treat migraine, which is ...

Mounting evidence indicates that calcitonin gene-related peptide (CGRP) has a key role in migraine, but full appreciation of the nature of its involvement has remained elusive, owing in part to a ...